JP2022536043A5 - - Google Patents

Info

Publication number
JP2022536043A5
JP2022536043A5 JP2021570326A JP2021570326A JP2022536043A5 JP 2022536043 A5 JP2022536043 A5 JP 2022536043A5 JP 2021570326 A JP2021570326 A JP 2021570326A JP 2021570326 A JP2021570326 A JP 2021570326A JP 2022536043 A5 JP2022536043 A5 JP 2022536043A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
group
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021570326A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536043A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/034794 external-priority patent/WO2020243224A1/en
Publication of JP2022536043A publication Critical patent/JP2022536043A/ja
Publication of JP2022536043A5 publication Critical patent/JP2022536043A5/ja
Pending legal-status Critical Current

Links

JP2021570326A 2019-05-28 2020-05-28 シトクロムｂｃ１阻害剤とクラリスロマイシン又はアジスロマイシン及びクロファジミンを組み合わせることを特徴とするマイコバクテリア感染症治療用医薬 Pending JP2022536043A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962853273P 2019-05-28 2019-05-28
US62/853,273 2019-05-28
PCT/US2020/034794 WO2020243224A1 (en) 2019-05-28 2020-05-28 A MEDICAMENT FOR TREATING MYCOBACTERIAL INFECTION CHARACTERIZED BY COMBINING A CYTOCHROME bc1 INHIBITOR WITH CLARITHROMYCIN OR AZITHROMYCIN AND CLOFAZIMINE

Publications (2)

Publication Number Publication Date
JP2022536043A JP2022536043A (ja) 2022-08-12
JP2022536043A5 true JP2022536043A5 (enExample) 2023-05-31

Family

ID=73553908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570326A Pending JP2022536043A (ja) 2019-05-28 2020-05-28 シトクロムｂｃ１阻害剤とクラリスロマイシン又はアジスロマイシン及びクロファジミンを組み合わせることを特徴とするマイコバクテリア感染症治療用医薬

Country Status (4)

Country Link
US (1) US20220235047A1 (enExample)
EP (1) EP3976031A4 (enExample)
JP (1) JP2022536043A (enExample)
WO (1) WO2020243224A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI861208B (zh) * 2019-09-10 2024-11-11 日商鹽野義製藥股份有限公司 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物
WO2022119899A1 (en) * 2020-12-02 2022-06-09 Shionogi & Co., Ltd. A medicament for treating mycobacterial infection characterized by combining a cytochrome bc1 inhibitor with clarithromycin or azithromycin
IL313296A (en) * 2021-12-07 2024-08-01 An2 Therapeutics Inc Treatment of mycobacterial infection without tuberculosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3316969T2 (ro) * 2015-07-02 2022-07-31 Janssen Sciences Ireland Unlimited Co Compuși antibacterieni
PE20181352A1 (es) * 2015-09-17 2018-08-22 Marvin J Miller Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias
EP3266454A1 (en) * 2016-07-07 2018-01-10 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Acc inhibitors for use in treating mycobacterial diseases
MA47676A (fr) * 2017-03-01 2021-06-02 Janssen Sciences Ireland Unlimited Co Polythérapie

Similar Documents

Publication Publication Date Title
JP2005509642A5 (enExample)
JP2021515010A5 (enExample)
KR970061865A (ko) 신규 치환된 구아니딘 유도체, 그의 제조방법, 및 그의 약제학적 용도
ATE19878T1 (de) Benzimidazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
MA27390A1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
WO2005007143A2 (en) Use of makrolides and ketolides for the treatment of tuberculosis
JP2022541545A5 (enExample)
CA2367319A1 (en) Erythromycin derivatives
HUP0100853A2 (hu) Fekély kezelésére alkalmas nitrátsók és ilyen vegyületeket tartalmazó gyógyászati készítmények
KR890016017A (ko) 치환된 1-(1h-이미다졸-4-일)알킬-벤즈아미드
JP2026503618A5 (enExample)
IL292635A (en) Prodrugs of Itacont and Methyl Itacont
WO2024107783A3 (en) Novel macrocyclic chalcone-amide derived antiviral agents
ATE342266T1 (de) 1-methylcarbapenemderivate
NO323556B1 (no) Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter.
DK455285D0 (da) 2-pyridin-thiolderivater
RU2004109817A (ru) Производные аминопиррола в качестве противовоспалительных средств
WO2022253884A4 (en) Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis
JP2007500205A5 (enExample)
JP2008519848A5 (enExample)
TN2011000266A1 (fr) Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique
US20230416294A1 (en) Decitabine analogs for immunological and oncological therapy
JP2024032794A5 (enExample)
CN120965662A (zh) 一种化合物在制备分枝杆菌抑制剂中的用途
BR122025025013A2 (pt) Compostos de itaconato e itaconato de metila, composição farmacêutica compreendendo os ditos compostos e usos dos mesmo no tratamento de uma doença, transtorno ou condição associado com inflamação